Shares of IntriCon Co. (NASDAQ:IIN) have been assigned an average rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $51.67.
A number of equities analysts have recently issued reports on IIN shares. Zacks Investment Research cut shares of IntriCon from a “buy” rating to a “hold” rating in a research note on Friday, November 2nd. TheStreet cut shares of IntriCon from a “b” rating to a “c+” rating in a research note on Monday, October 1st. Dougherty & Co cut shares of IntriCon from a “buy” rating to a “neutral” rating and set a $12.00 price objective for the company. in a research note on Tuesday, September 11th. B. Riley increased their price objective on shares of IntriCon from $45.00 to $55.00 and gave the company a “buy” rating in a research note on Monday, July 16th. Finally, Stifel Nicolaus increased their price objective on shares of IntriCon from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Friday, September 21st.
IntriCon stock traded down $1.45 during mid-day trading on Friday, reaching $39.95. The company had a trading volume of 178,995 shares, compared to its average volume of 184,880. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.56 and a quick ratio of 0.85. IntriCon has a 52 week low of $14.36 and a 52 week high of $76.80. The company has a market cap of $357.12 million, a PE ratio of 137.76, a price-to-earnings-growth ratio of 4.68 and a beta of 0.93.
In other news, Director Philip Irving Smith sold 10,000 shares of the stock in a transaction on Friday, August 31st. The shares were sold at an average price of $74.18, for a total value of $741,800.00. Following the completion of the transaction, the director now owns 6,667 shares in the company, valued at approximately $494,558.06. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 21.20% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Columbus Circle Investors acquired a new stake in shares of IntriCon during the 3rd quarter worth about $2,829,000. Integrated Investment Consultants LLC acquired a new stake in shares of IntriCon during the 2nd quarter worth about $308,000. Rhumbline Advisers acquired a new stake in shares of IntriCon during the 2nd quarter worth about $232,000. Bank of New York Mellon Corp acquired a new stake in shares of IntriCon during the 2nd quarter worth about $741,000. Finally, ClariVest Asset Management LLC acquired a new stake in shares of IntriCon during the 2nd quarter worth about $608,000. Institutional investors and hedge funds own 39.42% of the company’s stock.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
Further Reading: What is the NASDAQ Stock Market?
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.